Cargando…

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

Background: For multiple myeloma (MM), the proportions of patients reaching the subsequent line of therapy (LOT) decline gradually and real-world data describing the attrition rates of LOT in Chinese MM were limited. Herein, we investigated the attrition rates by subsequent LOTs and their relevant r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Wenjiao, Yang, Jinrong, Li, Yan, Zhang, Li, Li, He, Wang, Jie, Liao, Yi, Zhang, Chunlan, Qu, Ying, Zheng, Yuhuan, Niu, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877623/ https://www.ncbi.nlm.nih.gov/pubmed/36713847 http://dx.doi.org/10.3389/fphar.2023.979111

Ejemplares similares

P09: ATTRITION RATES IN MULTIPLE MYELOMA UNDER REAL WORLD CONDITIONS – AN ANALYSIS FROM THE AUSTRIAN MYELOMA REGISTRY
por: Benda, MA, et al.
Publicado: (2022)

Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)
por: Benda, Magdalena A., et al.
Publicado: (2023)

Real-world treatment attrition rates in advanced esophagogastric cancer
por: Tsang, Erica S, et al.
Publicado: (2020)

Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data
por: He, Jingsong, et al.
Publicado: (2020)

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China
por: Zou, Zhongqing, et al.
Publicado: (2021)

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum
por: Zou, Zhongqing, et al.
Publicado: (2022)

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS
por: Yang, Zheng, et al.
Publicado: (2022)

P47 REAL-WORLD DATA OF ATTRITION RATES BY SUBSEQUENT LINES OF THERAPY IN MULTIPLE MYELOMA PATIENTS TREATED IN A TERTIARY CARE ITALIAN CENTRE
por: Morè, S., et al.
Publicado: (2023)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
por: Zhang, Qiongwen, et al.
Publicado: (2023)

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China
por: Zhong, Linda LD., et al.
Publicado: (2022)

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
por: Ma, Yiming, et al.
Publicado: (2021)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China
por: Ji, Xiaojian, et al.
Publicado: (2019)

Safety and efficacy of compound methyl salicylate liniment for topical pain: A multicenter real-world study in China
por: Guo, Jie, et al.
Publicado: (2022)

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study
por: Cheng, Wei, et al.
Publicado: (2021)

Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development
por: Leil, Tarek A., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data
por: Zhao, Jie, et al.
Publicado: (2022)

Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
por: Yang, Lu, et al.
Publicado: (2022)

Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
por: Li, Na, et al.
Publicado: (2023)

A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma
por: Tang, Wenjiao, et al.
Publicado: (2022)

Methylxanthine Treatment in Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: A Real-World Study Using Propensity Score Matching Analysis
por: Zhan, Zijie, et al.
Publicado: (2022)

Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis
por: Hou, Liyan, et al.
Publicado: (2023)

Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
por: Huang, Kaituo, et al.
Publicado: (2023)

Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020
por: Jin, Jing, et al.
Publicado: (2022)

The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques
por: Ma, Jing, et al.
Publicado: (2023)

Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching
por: Wei, An-Hua, et al.
Publicado: (2023)

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma
por: Fonseca, Rafael, et al.
Publicado: (2020)

Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis
por: Zhou, Yu, et al.
Publicado: (2022)

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM
por: Shi, Xiaoping, et al.
Publicado: (2021)

Identifying subgroups of patients with type 2 diabetes based on real-world traditional chinese medicine electronic medical records
por: Zhao, Shuai, et al.
Publicado: (2023)

Safety and Efficacy Analysis of Selinexor-Based Treatment in Multiple Myeloma, a Meta-Analysis Based on Prospective Clinical Trials
por: Tao, Yali, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
por: Wang, Li, et al.
Publicado: (2021)

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
por: Lee, Yueh-Ting, et al.
Publicado: (2021)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

Real-World Prescription Patterns For Patients With Young-Onset Parkinson’s Disease in China: A Trend Analysis From 2014 to 2019
por: Liu, Xiao-qin, et al.
Publicado: (2022)

Effectiveness and Economic Evaluation of Polyene Phosphatidyl Choline in Patients With Liver Diseases Based on Real-World Research
por: Fan, Jian-Gao, et al.
Publicado: (2022)

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
por: McCurdy, Arleigh, et al.
Publicado: (2023)

Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence
por: Zheng, Ping, et al.
Publicado: (2021)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
por: Bérard, Anick
Publicado: (2021)

Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fbul53b1gci0f179e7pn5k7aig